An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries
J. Connor Wells(Queen's University), Christopher M. Booth(Queen's University), Ajay Aggarwal(London School of Hygiene & Tropical Medicine), C.S. Pramesh(Homi Bhabha National Institute), Richard Sullivan(King's College London), Wilma M. Hopman(Queen's University), Nazik Hammad(Queen's University), Joseph C. Del Paggio(Thunder Bay Regional Health Sciences Centre), Shubham Sharma(Queen's University), Deborah Mukherji(American University of Beirut Medical Center), Bishal Gyawali(Nagoya University Hospital)
Cited by 165
Related Papers
The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
|The Lancet Oncology|2020|1.9k
Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area
|JAMA|2003|1.4k
Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer
|JAMA|2011|632
Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence
|British Journal of Cancer|2014|470